Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.

C Manegold; P Drings; A Pawinski; M A Lentz; M van Glabbeke; N van Zandwijk; P Bachmann; Y Schnaars; Z Skacel; P Zatloukal

doi:10.1093/oxfordjournals.annonc.a010683

Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.

Identifier:nobleid.org/w1/20260515/490EB23C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/490EB23C.svg?ark=w1%2F20260515%2F490EB23C)](https://nobleid.org/work/w1/20260515/490EB23C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.

Identifier:nobleid.org/w1/20260515/490EB23C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/490EB23C.svg?ark=w1%2F20260515%2F490EB23C)](https://nobleid.org/work/w1/20260515/490EB23C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work